L. Tamer Et Al. , "Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atheroscleerotic patients," ARCHIVES OF MEDICAL RESEARCH , vol.33, pp.257-260, 2002
Tamer, L. Et Al. 2002. Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atheroscleerotic patients. ARCHIVES OF MEDICAL RESEARCH , vol.33 , 257-260.
Tamer, L., Sucu, N., Polat, G., Ercan, B., Aytacoglu, B., YÜCEBİLGİÇ, G., ... Ünlü, A.(2002). Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atheroscleerotic patients. ARCHIVES OF MEDICAL RESEARCH , vol.33, 257-260.
Tamer, Lülüfer Et Al. "Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atheroscleerotic patients," ARCHIVES OF MEDICAL RESEARCH , vol.33, 257-260, 2002
Tamer, Lülüfer Et Al. "Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atheroscleerotic patients." ARCHIVES OF MEDICAL RESEARCH , vol.33, pp.257-260, 2002
Tamer, L. Et Al. (2002) . "Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atheroscleerotic patients." ARCHIVES OF MEDICAL RESEARCH , vol.33, pp.257-260.
@article{article, author={Lülüfer Tamer Et Al. }, title={Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atheroscleerotic patients}, journal={ARCHIVES OF MEDICAL RESEARCH}, year=2002, pages={257-260} }